Menu

Blog

Archive for the ‘biotech/medical’ category: Page 46

May 14, 2024

Integrating population genetics, stem cell biology and cellular genomics to study complex human diseases

Posted by in categories: biotech/medical, genetics

Integrating human pluripotent stem cell models with population genetics and cellular genomics can help elucidate functional mechanisms underlying complex disease risk loci and uncover relationships between common genetic variation and pharmacotherapeutic phenotypes.

May 14, 2024

Engineers develop innovative microbiome analysis software tools

Posted by in categories: biotech/medical, innovation

Since the first microbial genome was sequenced in 1995, scientists have reconstructed the genomic makeup of hundreds of thousands of microorganisms and have even devised methods to take a census of bacterial communities on the skin, in the gut, or in soil, water and elsewhere based on bulk samples, leading to the emergence of a relatively new field of study known as metagenomics.

May 14, 2024

MRI enables detection of light deep inside the brain

Posted by in categories: biotech/medical, neuroscience

Engineers at MIT have developed a groundbreaking method for detecting bioluminescent light within the brain.

By modifying the brain’s blood vessels to express a specific protein, they induced dilation in response to light exposure.

The approach enabled researchers to visualize the dilation using magnetic resonance imaging (MRI), facilitating precise localization of light sources within the brain.

May 13, 2024

KAN: Kolmogorov-Arnold Networks | Ziming Liu

Posted by in categories: biotech/medical, robotics/AI

Chapters 00:00 — Intro + Background 05:06 — From KART to KAN 07:56 — MLP vs KAN 16:05 — Accuracy: Scaling of KANs 26:35 — Interpretability: KAN for Science 38:04 — Q+A Break 57:15 — Strengths and Weaknesses 59:28 — Philosophy 1:08:45 — Anecdotes Behind the Scenes…


Portal is the home of the AI for drug discovery community. Join for more details on this talk and to connect with the speakers: https://portal.valencelabs.com/logg.

Continue reading “KAN: Kolmogorov-Arnold Networks | Ziming Liu” »

May 13, 2024

Nanotechnology as a Shield against COVID-19: Current Advancement and Limitations

Posted by in categories: biotech/medical, economics, health, nanotechnology

The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global health problem that the WHO declared a pandemic. COVID-19 has resulted in a worldwide lockdown and threatened to topple the global economy. The mortality of COVID-19 is comparatively low compared with previous SARS outbreaks, but the rate of spread of the disease and its morbidity is alarming. This virus can be transmitted human-to-human through droplets and close contact, and people of all ages are susceptible to this virus. With the advancements in nanotechnology, their remarkable properties, including their ability to amplify signal, can be used for the development of nanobiosensors and nanoimaging techniques that can be used for early-stage detection along with other diagnostic tools.

May 13, 2024

Cancer-fighting nanorobots seek and destroy tumors

Posted by in categories: bioengineering, biotech/medical, nanotechnology, robotics/AI

Editor’s note: This story is being highlighted in ASU Now’s year in review. Read more top stories from 2018 here.

In a major advancement in nanomedicine, Arizona State University scientists, in collaboration with researchers from the National Center for Nanoscience and Technology (NCNST) of the Chinese Academy of Sciences, have successfully programmed nanorobots to shrink tumors by cutting off their blood supply.

“We have developed the first fully autonomous, DNA robotic system for a very precise drug design and targeted cancer therapy,” said Hao Yan, director of the ASU Biodesign Institute’s Center for Molecular Design and Biomimetics and the Milton Glick Professor in the School of Molecular Sciences.

May 13, 2024

Human ancestors may have almost died out after ancient population crash

Posted by in categories: biotech/medical, existential risks

Almost 99% of all human ancestors may have been wiped out around 930,000 years ago, a new paper has claimed.

The new research, published in the journal Science, used DNA from living people to suggest that humans went through a bottleneck, an event where populations shrink drastically. The paper estimates that as few as 1,300 humans were left for a period of around 120,000 years.

While the exact causes aren’t certain, the near-extinction has been blamed on Africa’s climate getting much colder and drier.

May 13, 2024

There’s a new COVID-19 variant called FLiRT: Here’s what you need to know about it

Posted by in category: biotech/medical

There’s a new COVID variant nicknamed “FLiRT.” Here’s what you need to know about the variant, including the symptoms.

May 13, 2024

Researchers publish largest-ever dataset of neural connections

Posted by in categories: biotech/medical, information science, robotics/AI

Scientists have published the most detailed data set to date on the neural connections of the brain, which was obtained from a cubic millimeter of tissue sample.


A cubic millimeter of brain tissue may not sound like much. But considering that that tiny square contains 57,000 cells, 230 millimeters of blood vessels, and 150 million synapses, all amounting to 1,400 terabytes of data, Harvard and Google researchers have just accomplished something stupendous.

Led by Jeff Lichtman, the Jeremy R. Knowles Professor of Molecular and Cellular Biology and newly appointed dean of science, the Harvard team helped create the largest 3D brain reconstruction to date, showing in vivid detail each cell and its web of connections in a piece of temporal cortex about half the size of a rice grain.

Continue reading “Researchers publish largest-ever dataset of neural connections” »

May 13, 2024

Common Antibiotic may be Helpful in Fighting Respiratory Viral Infections

Posted by in category: biotech/medical

A new, Yale-led study suggests that a range of respiratory viral infections—including COVID-19 and influenza—may be preventable or treatable with a generic antibiotic that is delivered to the nasal passageway.

A team led by Yale’s Akiko Iwasaki and former Yale researcher Charles Dela Cruz successfully tested the effectiveness of neomycin, a common antibiotic, to prevent or treat respiratory viral infections in animal models when given to the animals via the nose. The team then found that the same nasal approach—this time applying the over-the-counter ointment Neosporin—also triggers a swift immune response by interferon-stimulated genes (ISGs) in the noses of healthy humans.

The findings were published in the journal Proceedings of the National Academy of Sciences.

Page 46 of 2,630First4344454647484950Last